Please login to the form below
Access and elimination: the future of DAAs in hepatitis C
Published in Pharmaphorum January 2017
The dramatic improvements in safety, efficacy, tolerability and convenience from the first wave of direct-acting antivirals (DAAs) have made a substantial contribution to changing both the treatment paradigm and the long-term prognosis for hepatitis C.
The arrival of interferon-free, orally administered direct-acting antivirals (DAAs) in 2014 was a leap forward for the treatment of hepatitis C (HCV), a disease responsible for some 700,000 deaths globally each year.
http://www.researchpartnership.com/news/2017/01/access-and-elimination-the-future-of-daas-in-hepatit...
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- New syndicated reports now available
- Living with CD, PsO, IPF & PF-ILD 2023
Research Partnership
- Article: Could combating stigma increase the uptake of PrEP and finally end the HIV epidemic?
- In this article we explore what more could be done by the pharmaceutical industry to help prevent the spread of HIV infection worldwide.
Research Partnership
- Webinar: China Update 2023: How will recent developments impact your brand’s success?
- Register for this live webinar in which emerging market experts provide an update regarding the implications of changing demographics and the healthcare landscape.
Research Partnership
- Webcast: How to improve the patient journey through an effective engagement and activation strategy
- Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.
Research Partnership
- Webcast: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Watch part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years.
Research Partnership
- Infographic: Living with: The journey from the patient’s perspective
- View our re-vamped interactive infographic to unlock key insights from various Living With reports
Research Partnership
